Hepatitis B vaccine by intradermal route in non responder patients: An update

doi:10.3748/wjg.v20.i30.10383

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 30

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11029)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-1) series.

Item

Count

PDF

807

WORD

353

HTML

7664

Tables (1-1)

191

Sum=9015

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1091

Download

913

Sum=2004

Aug 14, 2014 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (61)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Aug 14, 2014; 20(30): 10383-10394
Published online Aug 14, 2014. doi: 10.3748/wjg.v20.i30.10383

Hepatitis B vaccine by intradermal route in non responder patients: An update

Martina Filippelli, Elena Lionetti, Alessia Gennaro, Angela Lanzafame, Teresa Arrigo, Carmelo Salpietro, Mario La Rosa, Salvatore Leonardi

Martina Filippelli, Elena Lionetti, Alessia Gennaro, Angela Lanzafame, Mario La Rosa, Salvatore Leonardi, Department of Medical and Pediatric Science, University of Catania, 95100 Catania, Italy

Teresa Arrigo, Carmelo Salpietro, Department of Pediatric Sciences, University of Messina, 98100 Messina, Italy

Author contributions: Filippelli M and Leonardi S participated in the conception and design of the review, manuscript writing and revision; Lionetti E, Gennaro A, Lanzafame A, Arrigo T, Salpietro C and La Rosa M participated manuscript writing; all authors read and approved the final manuscript.

Correspondence to: Salvatore Leonardi, Professor, Department of Medical and Pediatric Science, University of Catania, Via S Sofia 78, 95100 Catania, Italy. leonardi@unict.it

Telephone: +39-9-53782764 Fax: +39-9-53782895

Received: November 29, 2013
Revised: March 12, 2014
Accepted: April 27, 2014
Published online: August 14, 2014
Processing time: 261 Days and 21.1 Hours

Core Tip

Core tip: Vaccination is the principal strategy to reduce the morbidity and mortality caused by hepatitis B virus. Vaccinated subjects with an hepatitis B surface antibody titer less than 10 mIU/mL after primary vaccine series are considered “no responders”. There are chronic conditions that are characterized by a poorer response to hepatitis B virus vaccination than healthy subjects. To date it is still unclear how to treat this group of patients at high risk of hepatitis B infection. This review focuses on the use of anti hepatitis B vaccine by intradermal route as alternative to conventional intramuscular vaccine in all non responder patients.